本页面由Tiger Trade Technology Pte. Ltd.提供服务

Eikon Therapeutics

11.16
-0.2300-2.02%
成交量:39.84万
成交额:455.72万
市值:6.02亿
市盈率:-1.88
高:11.92
开:11.59
低:10.94
收:11.39
52周最高:17.40
52周最低:7.90
股本:5,398.43万
流通股本:1,764.80万
量比:0.54
换手率:2.26%
股息:- -
股息率:- -
每股收益(TTM):-5.9500
每股收益(LYR):-115.2900
净资产收益率:-125.02%
总资产收益率:-36.19%
市净率:1.29
市盈率(LYR):-0.10

数据加载中...

2026/08/14

重要事件披露

Form 8-K - Current report
2026/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/14

重要事件披露

Form 8-K - Current report
2026/08/06

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/04

重要事件披露

Form 8-K - Current report
2026/06/11

重要事件披露

Form 8-K - Current report
2026/06/01

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/13

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/11

重要事件披露

Form 8-K - Current report
2026/05/06

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/29

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/30

重要事件披露

Form 8-K - Current report
2026/03/30

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/06

重要事件披露

Form 8-K - Current report
2026/02/06

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/01/28

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/01/09

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933